ZBH Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 23:00):

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
Объем за сегодня	1.36M
Средний объем	1.42M
Рыночная капитализация	25.40B
EPS	$0 ( 2024-05-02 )
Дата следующего отчета о доходах	( $2.00 ) 2024-07-30
Last Dividend	$0.240 ( 2023-09-28 )
Next Dividend	$0 ( N/A )
P/E	56.85
ATR14	$0.0780 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Winkler Lori	Buy	772	Common Stock
2024-04-01	Winkler Lori	Sell	215	Common Stock
2024-04-01	Winkler Lori	Sell	772	Restricted Stock Units
2024-03-31	Michelson Michael W	Buy	207	Phantom Stock Units
2024-03-31	Hilado Maria Teresa	Buy	207	Phantom Stock Units

INSIDER POWER
10.08
Last 99 transactions
Buy: 197 885 \| Sell: 163 900

Объем Корреляция

Длинно: 0.40 (neutral)

Кратко: 0.43 (neutral)

Signal:(54.152) Neutral

Zimmer Biomet Holdings Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Zimmer Biomet Holdings Корреляция - Валюта/Сырье

0.41
( neutral )

0.14
( neutral )

0.00
( neutral )

-0.30
( neutral )

-0.33
( neutral )

-0.11
( neutral )

Zimmer Biomet Holdings Финансовые показатели

Annual	2023
Выручка:	$7.39B
Валовая прибыль:	$4.66B (63.06 %)
EPS:	$4.91

FY	2023
Выручка:	$7.39B
Валовая прибыль:	$4.66B (63.06 %)
EPS:	$4.91

FY	2022
Выручка:	$6.94B
Валовая прибыль:	$4.92B (70.90 %)
EPS:	$1.390

FY	2021
Выручка:	$7.84B
Валовая прибыль:	$5.50B (70.13 %)
EPS:	$1.930

Financial Reports:

No articles found.

Zimmer Biomet Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.240 (N/A)	$0.240 (N/A)	$0.240 (N/A)	$0.480 (N/A)	$0.240 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Zimmer Biomet Holdings Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.49 - good (94.94%) | Divividend Growth Potential Score: 3.70 - Decrease likely (26.00%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.175	2012-03-28
Last Dividend	$0.240	2023-09-28
Next Dividend	$0	N/A
Payout Date	2023-10-31
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$10.70	--
Avg. Dividend % Per Year	0.48%	--
Score	4.15	--
Div. Sustainability Score	9.49
Div.Growth Potential Score	3.70
Div. Directional Score	6.60	--

Next Divdend (Est)
(2024-07-01)

$0.244 Estimate 22.50 %

Dividend Stability

0.60 Above Average

Dividend Score

4.15

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.700	1.34%
2013	$0.776	1.18%
2014	$0.856	0.96%
2015	$0.856	0.78%
2016	$0.932	0.94%
2017	$0.932	0.93%
2018	$0.932	0.77%
2019	$0.932	0.94%
2020	$0.932	0.64%
2021	$0.932	0.63%
2022	$0.960	0.77%
2023	$0.960	0.75%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.138	1.500	7.23	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0476	1.200	8.41	10.00	[0 - 0.3]
returnOnEquityTTM	0.0827	1.500	-0.192	-0.289	[0.1 - 1]
payoutRatioTTM	0.196	-1.000	8.04	-8.04	[0 - 1]
currentRatioTTM	1.613	0.800	6.93	5.55	[1 - 3]
quickRatioTTM	0.650	0.800	-0.881	-0.704	[0.8 - 2.5]
cashRatioTTM	0.146	1.500	-0.303	-0.454	[0.2 - 2]
debtRatioTTM	0.271	-1.500	5.49	-8.23	[0 - 0.6]
interestCoverageTTM	6.75	1.000	8.61	8.61	[3 - 30]
operatingCashFlowPerShareTTM	7.58	2.00	7.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.39	2.00	7.30	10.00	[0 - 20]
debtEquityRatioTTM	0.466	-1.500	8.13	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.718	1.000	1.363	1.363	[0.2 - 0.8]
operatingProfitMarginTTM	0.184	1.000	8.33	8.33	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.272	1.000	9.60	9.60	[0.2 - 2]
assetTurnoverTTM	0.344	0.800	-1.040	-0.832	[0.5 - 2]
Total Score				9.49

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	24.78	1.000	7.60	0	[1 - 100]
returnOnEquityTTM	0.0827	2.50	-0.124	-0.289	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.39	2.00	8.20	10.00	[0 - 30]
dividendYielPercentageTTM	0.395	1.500	0.136	0	[0 - 0.4]
operatingCashFlowPerShareTTM	7.58	2.00	7.47	10.00	[0 - 30]
payoutRatioTTM	0.196	1.500	8.04	-8.04	[0 - 1]
pegRatioTTM	-0.265	1.500	-5.10	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.214	1.000	7.15	0	[0.1 - 0.5]
Total Score				3.70

Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.